QuickView for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=9A293F9B4FD554D3CFAA1B9898B171E8;jsessionid=C8B5755C1AB667BEC9CC28337B057DA7;jsessionid=32AD4D9B0B05B0E92996C29EF67EF5E1;jsessionid=CC0AB0DEC461DDE0D45D9081D943E682;jsessionid=C56E39DAAA5423A3E4CE643470A76F05;jsessionid=4B88A1778BFAC87DA10FC26B591FBCCD;jsessionid=4E4C71B9E5CB718BFCE60FF4F0B63FBD (gene)

1. Thymic stroma and TFII-I: towards new targeted therapies.
2. Proteomic analysis of SRF associated transcription complexes identified TFII-I as modulator of SRF f…
3. Structural basis for evolutionarily conserved interactions between TFIIS and Paf1C.
4. The TFIIS N-terminal domain (TND): a transcription assembly module at the interface of order and dis…
5. Identification of novel regulatory NFAT and TFII-I binding elements in the calbindin-D28k promoter i…

There were no clinical trials for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=9A293F9B4FD554D3CFAA1B9898B171E8;jsessionid=C8B5755C1AB667BEC9CC28337B057DA7;jsessionid=32AD4D9B0B05B0E92996C29EF67EF5E1;jsessionid=CC0AB0DEC461DDE0D45D9081D943E682;jsessionid=C56E39DAAA5423A3E4CE643470A76F05;jsessionid=4B88A1778BFAC87DA10FC26B591FBCCD;jsessionid=4E4C71B9E5CB718BFCE60FF4F0B63FBD